Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The need of radiotherapy optimization for glioblastomas considering immune responses.
Nishioka K, Takahashi S, Mori T, Uchinami Y, Yamaguchi S, Kinoshita M, Yamashina M, Higaki H, Maebayashi K, Aoyama H. Nishioka K, et al. Among authors: maebayashi k. Jpn J Radiol. 2023 Oct;41(10):1062-1071. doi: 10.1007/s11604-023-01434-x. Epub 2023 Apr 18. Jpn J Radiol. 2023. PMID: 37071249 Free PMC article. Review.
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.
Muragaki Y, Ishikawa E, Maruyama T, Nitta M, Saito T, Ikuta S, Komori T, Kawamata T, Yamamoto T, Tsuboi K, Matsumura A, Nakamura H, Kuroda J, Abe T, Momii Y, Saito R, Tominaga T, Tabei Y, Suzuki I, Arakawa Y, Miyamoto S, Matsutani M, Karasawa K, Nakazato Y, Maebayashi K, Hashimoto K, Ohno T. Muragaki Y, et al. Among authors: maebayashi k. J Neurosurg. 2023 Jan 20;139(2):344-354. doi: 10.3171/2022.12.JNS221221. Print 2023 Aug 1. J Neurosurg. 2023. PMID: 36670529 Clinical Trial.
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma.
Mikami E, Nakamichi S, Nagano A, Misawa K, Hayashi A, Tozuka T, Takano N, Noro R, Maebayashi K, Kubokura H, Terasaki Y, Kubota K, Seike M. Mikami E, et al. Among authors: maebayashi k. Intern Med. 2023 Sep 15;62(18):2731-2735. doi: 10.2169/internalmedicine.1142-22. Epub 2023 Jan 15. Intern Med. 2023. PMID: 36642523 Free PMC article.
Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.
Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K; Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) Investigators. Nakano T, et al. Among authors: maebayashi k. Clin Transl Radiat Oncol. 2022 Sep 27;37:116-129. doi: 10.1016/j.ctro.2022.09.005. eCollection 2022 Nov. Clin Transl Radiat Oncol. 2022. PMID: 36199814 Free PMC article.
Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.
Harada K, Igaki H, Abe E, Ariga T, Hayashi N, Kanemoto A, Komiyama T, Matsumoto Y, Nakano T, Onimaru R, Saito H, Sumi M, Tago M, Tanaka K, Maebayashi K, Aoyama H; Japanese Radiation Oncology Study Group (JROSG) Working Subgroup for Neurological Tumors. Harada K, et al. Among authors: maebayashi k. Int J Clin Oncol. 2018 Dec;23(6):1015-1022. doi: 10.1007/s10147-018-1313-4. Epub 2018 Jul 3. Int J Clin Oncol. 2018. PMID: 29971621
Ten-year follow-up study of Japanese patients with obsessive-compulsive disorder.
Nakajima A, Matsuura N, Mukai K, Yamanishi K, Yamada H, Maebayashi K, Hayashida K, Matsunaga H. Nakajima A, et al. Among authors: maebayashi k. Psychiatry Clin Neurosci. 2018 Jul;72(7):502-512. doi: 10.1111/pcn.12661. Epub 2018 May 21. Psychiatry Clin Neurosci. 2018. PMID: 29652103 Free article.
69 results